Cholestyramine Powder, For Suspension
Product Images NDC 51224-011

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cholestyramine (NDC 51224-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tagi Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cholestyramine 01)

Chemical structure of cholestyramine depicting its repeated aromatic rings with attached methyl and ethyl side chains, including the quaternary ammonium chloride group indicated as N+(CH3)3 Cl-.*

FDA Label Image

Principal Display Panel (8.3 g Pouch Label)

Cholestyramine for Oral Suspension, USP powder 4 grams per pouch, orange flavor, in single-dose pouches. The label shows 60 pouches per package, manufactured for TAGI Pharma, Inc., with instructions for preparation and use depicted in images and text. The packaging also includes storage instructions, healthful hints, a barcode, and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.